JS Link, Inc. (KOSDAQ:127120)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,130
-680 (-4.30%)
Last updated: Aug 7, 2025

JS Link Company Description

JS Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.

Its next generation sequencing services include whole genome sequencing, De Novo sequencing, whole exome/targeted sequencing, transcriptome sequencing, epigenome sequencing, and single-cell RNA sequencing.

The company also provides microarray services, such as DNA and microarray RNA analysis; Fluidigm BioMark System, an automated PCR/qPCR system; TaqMan assay; and SNaPshot assay.

In addition, it provides rare earth and permanent magnets. The company was formerly known as DNA Link, Inc. and changed its name to JS Link, Inc. in April 2025.

JS Link, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

JS Link, Inc.
CountrySouth Korea
Founded2000
IndustryBiological Products, Except Diagnostic Substances
Employees83
CEOJong-Eun Lee

Contact Details

Address:
31, Magokjungang 8-ro 3-gil
Seoul
South Korea
Phone82 2 3153 1500
Websitejslink.co.kr

Stock Details

Ticker Symbol127120
ExchangeKOSDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyKRW
SIC Code2836

Key Executives

NamePosition
Jong-Eun LeeChief Executive Officer